HIF1A and ovarian cancer: Moreover, RES was shown to effectively block lysophosphatidic acid (LPA)-induced hypoxia-inducible factor 1-alpha (HIF-1α) and vascular endothelial growth factor (VEGF) expression in OVCAR-3 and CAOV-3 ovarian cancer cells [50].